Status:
COMPLETED
Molecular Mechanisms Underlying Prostate Cancer Disparities
Lead Sponsor:
Duke University
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this study is to further elucidate the molecular mechanisms underlying prostate cancer disparities. In previous work the investigators have identified a set of differentially deregulate...
Detailed Description
Individual patient African American and Caucasian American prostate biopsy cores or surgical specimens will be obtained from the following procedures: transrectal ultrasound biopsy of the prostate (TR...
Eligibility Criteria
Inclusion
- Suspected malignancy of prostate cancer
- Self-reported race of African American or Caucasian American
- Age \>/= 18 years
- Able to read, understand and sign an informed consent document
Exclusion
- Collected tumor tissue is inadequate for DNA and RNA analysis and/or is not positive for adenocarcinoma of the prostate.
- Patients with prior systemic therapy will not be eligible for the study, i.e. radiation or chemo or immunotherapy.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 14 2019
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT02229565
Start Date
November 1 2014
End Date
October 14 2019
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710